Wednesday, February 10, 2010, 9:07am EST - Canadian Markets open in 23 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Trinity Biotech plc (TRIB)

 On Feb 9: 4.1139 USD   0.00 (0.00%)  
MORE ON TRIB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Trinity Biotech plc (NasdaqNM:TRIB) Delayed quote dataEdit
Last Trade: 4.1139 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 4.1139
Open: N/A
Bid: 3.95 x 2000
Ask: 4.27 x 300
1y Target Est: 10.80
Day's Range: N/A - N/A
52wk Range: 1.05 - 5.70
Volume: 0
Avg Vol (3m): 38,774.6
Market Cap: 86.16M
P/E (ttm): 11.30
EPS (ttm): 0.364
Div & Yield: N/A (N/A%)
Trinity Biotech plc (TRIB)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add TRIB to Portfolio   Download Data

HEADLINES
• Trinity Biotech Announces Third Quarter 2009 Financial Results
Marketwire (Wed, Oct 21)
• Trinity Biotech plc to Announce Third Quarter 2009 Financial Results on October 21, 2009
Marketwire (Wed, Oct 14)
• Trinity Biotech Announces Second Quarter 2009 Financial Results
Marketwire (Thu, Jul 23)
• Trinity Biotech Announces TRI-stat(TM) CLIA Submission to FDA
Marketwire (Mon, Jul 20)
• / CORRECTION - Trinity Biotech plc to Announce Second Quarter 2009 Financial Results on July 23, 2009
Marketwire (Mon, Jul 13)
• Trinity Biotech plc to Announce Second Quarter 2009 Financial Results on July 23, 2009
Marketwire (Mon, Jul 13)
• Trinity Biotech Receives FDA Approval for Destiny Max in the USA
Marketwire (Tue, Jul 7)
• 4-Star Stocks on the Upswing
at Motley Fool (Thu, Jun 11)
• Trinity Biotech Announces First Quarter 2009 Financial Results
Marketwire (Wed, Apr 29)
• Trinity Biotech plc to Announce First Quarter 2009 Financial Results
Marketwire (Wed, Apr 22)
More Headlines for TRIB...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Trinity Biotech plc develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market primarily in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices